| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | KIN001-236 | GDSC1000 | pan-cancer | AAC | 0.034 | 0.3 |
| mRNA | BRD-K99584050 | CTRPv2 | pan-cancer | AAC | -0.053 | 0.3 |
| mRNA | ML162 | CTRPv2 | pan-cancer | AAC | 0.033 | 0.3 |
| mRNA | YL54 | CTRPv2 | pan-cancer | AAC | 0.039 | 0.3 |
| mRNA | CGP-60474 | GDSC1000 | pan-cancer | AAC | 0.052 | 0.3 |
| mRNA | AP-24534 | GDSC1000 | pan-cancer | AAC | 0.033 | 0.3 |
| mRNA | PRL-3 Inhibitor I | CTRPv2 | pan-cancer | AAC | -0.038 | 0.3 |
| mRNA | HC-067047 | CTRPv2 | pan-cancer | AAC | -0.037 | 0.3 |
| mRNA | FK866 | GDSC1000 | pan-cancer | AAC | 0.03 | 0.3 |
| mRNA | navitoclax:sorafenib (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.034 | 0.3 |